Identification and characterization of chromatin regulators of HIV-1 latency
HIV-1 潜伏期染色质调节因子的鉴定和表征
基本信息
- 批准号:10423663
- 负责人:
- 金额:$ 48.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2022-04-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
After HIV integration of the proviral DNA into the host genome, the virus can remain latent or activate
transcription. The viral Tat protein, which enhances transcript elongation from the HIV-1 promoter, is the switch
between these two states. Since Tat resides under the control of the same promoter, it enhances its own
transcription via a positive feedback loop. We identified didehydro-Cortistatin A (dCA) as a very potent
inhibitor of Tat (1, 2). In human CD4 +T cells isolated from aviremic individuals, combining dCA with ART
accelerates HIV-1 suppression and prevents viral rebound during treatment interruption, as the HIV-1 promoter
remains epigenetically repressed. HIV-1 transcriptional inhibitors have the unique property of reducing particle
production from infected cells. dCA is the proof-of-concept that this novel class of molecules is amenable to
block-and-lock functional cure approaches, which aim at reducing residual viremia during ART and limit
viral rebound. It is thus important to understand the mechanisms that explain not only dCA's inhibition of
reactivation, but also mechanisms regulating HIV-1 latency in CD4+T memory T cells in general, to expand on
“block-and-lock” approaches, and explore alternative options for retroviral suppression.
There are approximately 320 human chromatin regulators, which “write”, “erase”, or “read” chromatin
modifications, or remodel nucleosome topology. Specificity in gene expression derives from the combinatorial
nature of chromatin modifications, and assembly of related chromatin regulator subunits. The rationale for this
proposal is that factors that establish HIV-1 latency are important for viral reactivation, and that by identifying
and inhibiting them, a “locked” state of silencing that is exceedingly resistant to reactivation can be achieved.
We propose to combine a comprehensive high-resolution mapping of the nucleosome
organization and positioning of chromatin remodeling complexes at the HIV promoter during HIV
latency, with a robust pooled shRNAs screening approach to interrogate all chromatin regulatory factors
in parallel during a single experiment. Primary and secondary screens will be performed in a newly developed
primary cell system that captures bona fide HIV-1 latency, and departs from CD4+T cells from successfully
treated HIV infected donors.
During the R61 phase of the project we will be able to correlate high-resolution nucleosome
architecture data with their binding to all chromatin remodeling machine families and develop a comprehensive
picture of the signals and factors that drive chromatin activity at the HIV-1 genome during latency. This data
will support robust hypotheses and targets to test in detail during the R33 phase. We anticipate that from these
candidates, we can infer how HIV-latency is controlled and develop rational therapeutic approaches to
modulate HIV latency.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susana T Valente其他文献
Potent suppression of HIV viral replication by a novel inhibitor of Tat
- DOI:
10.1186/1742-4690-9-s1-o11 - 发表时间:
2012-05-25 - 期刊:
- 影响因子:3.900
- 作者:
Guillaume Mousseau;Mark A Clementz;Wendy N Bakeman;Nisha Nagarsheth;Michael Cameron;Jun Shi;Phil Baran;Rémi Fromentin;Nicolas Chomont;Susana T Valente - 通讯作者:
Susana T Valente
Susana T Valente的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susana T Valente', 18)}}的其他基金
Development and characterization of HIV-1 Tat degraders
HIV-1 Tat 降解剂的开发和表征
- 批准号:
10483950 - 财政年份:2022
- 资助金额:
$ 48.74万 - 项目类别:
Host factors regulating HIV latency and reactivation
调节HIV潜伏期和再激活的宿主因素
- 批准号:
10516096 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Host factors regulating HIV latency and reactivation
调节HIV潜伏期和再激活的宿主因素
- 批准号:
10427641 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Validation and characterization of Tat inhibitors identified through HTS
通过 HTS 鉴定的 Tat 抑制剂的验证和表征
- 批准号:
10258019 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Validation and characterization of Tat inhibitors identified through HTS
通过 HTS 鉴定的 Tat 抑制剂的验证和表征
- 批准号:
10468812 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Host factors regulating HIV latency and reactivation
调节HIV潜伏期和再激活的宿主因素
- 批准号:
10403317 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Host factors regulating HIV latency and reactivation
调节HIV潜伏期和再激活的宿主因素
- 批准号:
10591707 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Validation and characterization of Tat inhibitors identified through HTS
通过 HTS 鉴定的 Tat 抑制剂的验证和表征
- 批准号:
10591875 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Identification and characterization of chromatin regulators of HIV-1 latency
HIV-1 潜伏期染色质调节因子的鉴定和表征
- 批准号:
9975693 - 财政年份:2018
- 资助金额:
$ 48.74万 - 项目类别:
Identification and characterization of chromatin regulators of HIV-1 latency
HIV-1 潜伏期染色质调节因子的鉴定和表征
- 批准号:
10591851 - 财政年份:2018
- 资助金额:
$ 48.74万 - 项目类别:
相似海外基金
varCUT&Tag: A Method for Simultaneous Identification and Characterization of Sequence Variants in Regulatory Elements and Genes
可变剪切
- 批准号:
10662799 - 财政年份:2023
- 资助金额:
$ 48.74万 - 项目类别:
Identification and characterization of molecular subtypes of Alzheimer's disease associated with cognitive function through cross-omics data integration
通过跨组学数据整合识别和表征与认知功能相关的阿尔茨海默病分子亚型
- 批准号:
10722083 - 财政年份:2023
- 资助金额:
$ 48.74万 - 项目类别:
Identification and characterization of mCpH binding proteins in neurons
神经元中 mCpH 结合蛋白的鉴定和表征
- 批准号:
10676980 - 财政年份:2022
- 资助金额:
$ 48.74万 - 项目类别:
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
与阿尔茨海默病和健康衰老相关的细胞特异性转座元件的鉴定和表征
- 批准号:
10518934 - 财政年份:2022
- 资助金额:
$ 48.74万 - 项目类别:
Identification and Characterization of Cell-Specific Transposable Elements Implicated on Alzheimer Disease and Healthy Aging
与阿尔茨海默病和健康衰老相关的细胞特异性转座元件的鉴定和表征
- 批准号:
10677894 - 财政年份:2022
- 资助金额:
$ 48.74万 - 项目类别:
Genome-wide identification and characterization of Alzheimer's Disease-associated enhancers
阿尔茨海默病相关增强子的全基因组鉴定和表征
- 批准号:
10621939 - 财政年份:2022
- 资助金额:
$ 48.74万 - 项目类别:
Identification of protein complex containing the chromatin remodeling factor DDM1 and characterization of its targeting mechanism on transposons
含有染色质重塑因子 DDM1 的蛋白质复合物的鉴定及其转座子靶向机制的表征
- 批准号:
21K20628 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Identification and characterization of chromatin regulators of coordinated synaptic gene expression
协调突触基因表达的染色质调节因子的鉴定和表征
- 批准号:
10391155 - 财政年份:2021
- 资助金额:
$ 48.74万 - 项目类别:
Identification and Characterization of Novel Cis-Regulatory Elements Controlling PTEN Expression
控制 PTEN 表达的新型顺式调控元件的鉴定和表征
- 批准号:
10318161 - 财政年份:2020
- 资助金额:
$ 48.74万 - 项目类别:
Identification and characterization of lncRNAs involved in genetic compensation
参与遗传补偿的lncRNA的鉴定和表征
- 批准号:
20K15784 - 财政年份:2020
- 资助金额:
$ 48.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists